InflaRx Reports Full Year 2019 Financial & Operating Results

NEXT STORY
Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
PREV STORY
SIGA Technologies to Host Business Update Call on May 6, 2020 after Release of First Quarter Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients

Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the study without ...

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Provides Corporate Update Highlighting Business Development and Clinical Pipeline Priorities

BEVERLY, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Horizon Pharma plc to Host Third-Quarter 2016 Conference Call and Webcast on November 7, 2016

DUBLIN, Ireland, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical ...

author_avatar
NASDAQ Market News